The Spatial Biology Company™

Akoya Launches Two New, Fully Optimized PD-1/PD-L1 Panels for Immuno-Oncology Biomarker Analysis of Melanoma and Lung Cancer

As part of our expanding solution for translational immuno-oncology analysis, we’ve launched two new immunofluorescence kits. The Opal™ MOTiF-based kits enable deep tissue profiling of the tumor microenviroment with clinically-relevant biomarkers, including PD-1 and PD-L1, in Melanoma and Lung Cancer samples. These complete staining kits include six ready-to-use primary antibodies, associate staining and assay reagents for automated slide staining and high throughput imaging on the Vectra® Polaris™. We announced the new panels at the 2019 Society for Immunotherapy of Cancer (SITC) annual meeting and presented data at the Akoya workshop and multiple poster presentations. Click here to read the full announcement. An overview of the new panels will be presented in a live webinar on Tuesday, December 17th. Click here to register for the webinar.